IMPEL PHARMACEUTICALS INC (IMPL) Stock Analyst Ratings
NASDAQ:IMPL - Nasdaq - US45258K1097 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to IMPL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 40.8. This target is 16822.44% above the current price.
IMPL was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IMPL.
In the previous month the buy percentage consensus was at a similar level.
IMPL was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-15 | Wedbush | Downgrade | Outperform -> Neutral |
| 2022-08-25 | JonesTrading | Initiate | Buy |
| 2021-05-18 | Guggenheim | Initiate | Buy |
| 2021-05-18 | Wedbush | Initiate | Outperform |